Scipio bioscience

Scipio bioscience had to cease its operations on 18/09/2024. At Scipio bioscience we were passionate about empowering every researcher to discover the molecular mechanisms of life for better health and a sustainable world. Enabling deeper insights into disease understanding, Scipio wanted to boost the access to and increases the pace of discoveries with its Asteria benchtop kit for easy scRNA-seq sample preparation and its Cytonaut intuitive cloud-based data analysis software for biologists and bioinformaticians alike. Scipio provided all researchers with empowered autonomy to embrace the next step in single-cell, working with unaltered transcriptomic data for the highest-quality results and true...

Biotechnology,biochemistry,genomics,transcriptomes,rna-seq,biophysics,and molecular biology

Scipio bioscience operates in the Biotechnology research industry.

Scipio bioscience's revenue is 1m - 10m

Scipio bioscience has 11 - 50 employees.